Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Barramundi (BRM) / HY26

Portfolio swung to unprecedented -5.8%, 11.4pp behind benchmark

Recurring investment income held above its historical range, but a NZ$13.5m portfolio loss pushed NPAT to -NZ$15.4m and NTA per share to NZ$0.63.

Investment Companies / Listed investment company

NTA/NAV per share

Net tangible asset or net asset value per share, shown in per-share cents for chart readability.

↗
Loading chart...
  • HY22 BRM: Unprecedented high nta/nav per share. 0.85x; 4-period range 0.63x to 0.75x. NTA/NAV per share: 0.85x, unprecedented high; 4-period mean 0.69x, range 0.63x-0.75x.
  • FY22 BRM: Outside range low nta/nav per share. 0.64x; 4-period range 0.72x to 30x. NTA/NAV per share: 0.64x, below normal range; 4-period mean 8.09x, range 0.72x-30.00x.
  • FY25 BRM: Unprecedented high nta/nav per share. 30x; 4-period range 0.64x to 0.87x. NTA/NAV per share: 30.00x, unprecedented high; 4-period mean 0.75x, range 0.64x-0.87x.
  • HY26 BRM: Outside range low nta/nav per share. 0.63x; 4-period range 0.65x to 0.85x. NTA/NAV per share: 0.63x, below normal range; 4-period mean 0.75x, range 0.65x-0.85x.
NTA/NAV per share: 0.63x, below normal range; 4-period mean 0.75x, range 0.65x-0.85x.

Investment income

Recurring investment-income or revenue-return proxy, excluding fair-value movement where disclosed.

↗
Loading chart...
  • FY21 BRM: Unprecedented low investment income. $2.9m; 4-period range $3.8m to $4.8m. Investment income: NZ$2.9m, unprecedented low; 4-period mean NZ$4.2m, range NZ$3.8m-NZ$4.8m.
  • HY22 BRM: Outside range low investment income. $1.9m; 4-period range $2m to $2.4m. Investment income: NZ$1.9m, below normal range; 4-period mean NZ$2.2m, range NZ$2.0m-NZ$2.4m.
  • FY25 BRM: Unprecedented high investment income. $4.8m; 4-period range $2.9m to $4.2m. Investment income: NZ$4.8m, unprecedented high; 4-period mean NZ$3.7m, range NZ$2.9m-NZ$4.2m.
  • HY26 BRM: Outside range high investment income. $2.4m; 4-period range $1.9m to $2.4m. Investment income: NZ$2.4m, above normal range; 4-period mean NZ$2.1m, range NZ$1.9m-NZ$2.4m.
Investment income: NZ$2.4m, above normal range; 4-period mean NZ$2.1m, range NZ$1.9m-NZ$2.4m.

Investment total return

Total income or return including fair-value or capital movement where disclosed.

↗
Loading chart...
  • FY21 BRM: Outside range high investment total return. $57.2m; 4-period range $-32.6m to $43.6m. Investment total return: NZ$57.2m, above normal range; 4-period mean NZ$14.1m, range NZ$-32.6m-NZ$43.6m.
  • FY22 BRM: Unprecedented low investment total return. $-32.6m; 4-period range $12.5m to $57.2m. Investment total return: NZ$-32.6m, unprecedented low; 4-period mean NZ$36.6m, range NZ$12.5m-NZ$57.2m.
  • HY24 BRM: Outside range high investment total return. $19.7m; 4-period range $-13.5m to $17.3m. Investment total return: NZ$19.7m, above normal range; 4-period mean NZ$8.3m, range NZ$-13.5m-NZ$17.3m.
  • HY26 BRM: Unprecedented low investment total return. $-13.5m; 4-period range $14.3m to $19.7m. Investment total return: NZ$-13.5m, unprecedented low; 4-period mean NZ$16.6m, range NZ$14.3m-NZ$19.7m.
Investment total return: NZ$-13.5m, unprecedented low; 4-period mean NZ$16.6m, range NZ$14.3m-NZ$19.7m.

Net assets attributable

Net asset base attributable to shareholders or unitholders.

↗
Loading chart...
  • FY22 BRM: Outside range low net assets attributable. $170.7m; 4-period range $185.7m to $240.6m. Net assets attributable: NZ$170.7m, below normal range; 4-period mean NZ$210.4m, range NZ$185.7m-NZ$240.6m.
  • HY23 BRM: Unprecedented low net assets attributable. $178.1m; 4-period range $211.1m to $248.3m. Net assets attributable: NZ$178.1m, unprecedented low; 4-period mean NZ$226.0m, range NZ$211.1m-NZ$248.3m.
  • HY25 BRM: Unprecedented high net assets attributable. $248.3m; 4-period range $178.1m to $225.9m. Net assets attributable: NZ$248.3m, unprecedented high; 4-period mean NZ$208.5m, range NZ$178.1m-NZ$225.9m.
  • FY25 BRM: Unprecedented high net assets attributable. $240.6m; 4-period range $170.7m to $215.9m. Net assets attributable: NZ$240.6m, unprecedented high; 4-period mean NZ$192.9m, range NZ$170.7m-NZ$215.9m.
Net assets attributable: NZ$240.6m, unprecedented high; 4-period mean NZ$192.9m, range NZ$170.7m-NZ$215.9m.
Release date
16 February 2026
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY26 vs HY25

Net profit after tax

−$15.4m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

−$13m

+12.2% ↑ vs −$14.8m

Interim dividend per share

1.3c

-16.3% ↓ vs 1.5c

Investment income

−$13.5m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Profit before tax

−$15m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Cash and cash equivalents

$2.8m

-80.9% ↓ vs $14.4m

Total assets

$221.7m

-11.3% ↓ vs $249.9m

What changed

Portfolio total return was -5.8% in HY26, an unprecedented low against the supplied historical range of 5.3%-8.9% (mean 7.7%), and trailed the benchmark return of 5.6% by 11.4pp

Investment total return swung to -NZ$13.5m versus a historical mean of NZ$16.6m, taking NPAT to -NZ$15.4m (HY25: NZ$8.9m) and PBT to -NZ$15.0m. NTA per share fell 14.4% to NZ$0.63, below the supplied historical NZ$0.65-NZ$0.85 range.

Underlying investment income (dividends and interest) rose 2.2% to NZ$2.4m, above its historical range. Total assets fell 11.3% to NZ$221.7m, equity fell 11.8% to NZ$218.9m, and cash dropped from NZ$14.4m to NZ$2.75m. Dividends paid in the period totalled 2.84cps; the newly declared interim dividend is 1.28cps, down from 1.53cps.

What matters

Benchmark underperformance is now consecutive

The 11.4pp gap between portfolio return (-5.8%) and benchmark (+5.6%) means this is not purely a market-direction story; the manager lost capital while the chosen yardstick generated a positive return. The prior interim also trailed benchmark, by 2.3pp, so HY26 is the second consecutive interim of active underperformance — a more important read on the vehicle than the magnitude of any one period.

NTA erosion exceeded the index move. Net assets attributable to shareholders fell 11.8% to NZ$218.9m and NTA per share dropped 14.4% to NZ$0.63, below the supplied historical range. Because distributions are paid from a mix of recurring income, realised gains and capital, drawdowns in NAV reduce the base from which future distributions can be sustained.

Distributions still rely on capital, not income. Recurring investment income covered 38.4% of distributions, within the historical 35.0%-41.1% range, so structurally about three-fifths of cash paid to shareholders continues to come from gains or capital. With portfolio return negative and cash down to NZ$2.75m from NZ$14.4m, the funding mix for the next interim distribution becomes a sharper question than in prior periods.

Expectations

No forward NAV, portfolio or distribution targets were supplied, and investment companies do not produce the kind of order-book or work-in-hand read used for operating businesses

The release therefore does not support a quantitative view on second-half NAV recovery or on whether portfolio return reverts toward the historical 7.7% mean.

What the release does establish is that the recurring-income leg held up while the capital-return leg deteriorated sharply. The declared interim dividend cut to 1.28cps (from 1.53cps) signals some adjustment to the realised capital position rather than a stated change in distribution policy. Reversion in HY27 will depend on Australian sharemarket conditions and active-manager performance, neither of which is disclosed forward in this filing.

Quality of result

The recurring component of the result is durable: investment income (dividends and interest) was NZ$2.4m, up 2.2% and above the supplied historical NZ$1.9m-NZ$2.4m range

That stream is not dependent on mark-to-market movements and represents the underlying yield generation of the portfolio.

The headline loss is driven almost entirely by fair-value movements on Australian-listed holdings — NZ$17.4m of losses on investments according to the commentary. These are revaluation movements rather than realised cash losses on the recurring income stream, and they reverse with market direction. The unprecedented-low classification on portfolio total return (-5.8% vs a 5.3%-8.9% historical range) and on investment total return therefore reflects market and active-manager performance against a baseline that did not include a comparable drawdown, rather than a structural change in the business model.

Cash conversion-style measures are not applicable to an investment vehicle. The relevant balance-sheet read is that cash fell to NZ$2.75m from NZ$14.4m, narrowing the buffer available to fund distributions without realising investments at depressed prices.

Unresolved

Open questions

What drove the 11.4pp underperformance versus benchmark in HY26, and how does the manager split it between stock selection and sector allocation?
Why has the portfolio now trailed its benchmark in two consecutive interim periods, and what changes (if any) are being made to the investment approach?
How will the next interim distribution be funded given recurring investment income covers only 38.4% of payouts and cash has fallen to NZ$2.75m?
Is the declared 1.28cps interim dividend a one-off response to the capital drawdown, or a step toward a lower run-rate distribution?
What is the manager's view on the durability of recurring investment income running above its historical range?

This briefing cannot assess the composition of the underlying portfolio, the manager's specific stock-level decisions, or the trajectory of Australian sharemarket conditions that drove the fair-value movements.

Chat

Ask about BRM HY26

Ask follow-up questions about Barramundi's HY26 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about BRM HY26

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Barramundi's HY26 result.

What drove the 11.4pp underperformance versus benchmark in HY26, and how does the manager split it between stock selection and sector allocation?Why does "Benchmark underperformance is now consecutive" matter?How strong was the cash and earnings quality in HY26?What should I watch next for BRM after HY26?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

BRM - Commentary for interim period to 31 December 2025

HY26 / results release↗

BRM - Interim Financial Statements for period to 31 Dec 2025 incl review report

HY26 / financial report↗

BRM - Preliminary half year announcement - 31 December 2025

HY26 / results announcement↗

Prior comparable period

BRM - Commentary for interim period to 31 December 2024

HY25 / results release↗

BRM - Interim Financial Statements for period to 31 Dec 2024 including review report

HY25 / financial report↗

BRM- Preliminary half year announcement - 31 December 2024

HY25 / results announcement↗

Full-year context

Barramundi 2025 Annual Report

FY25 / financial report↗

Release context

Barramundi ASM Presentation 31 Oct 2025

HY26 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

This result includes a statutory earnings-quality distortion flag.

→

ROE and capital efficiency

ROE was -7.1%, -10.7pp versus the prior comparable period.

→

Revenue growth context

Revenue growth was 2.2% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when BRM publishes next

Get the next Barramundi briefing and related NZX reporting-season updates by email.